Trials / Completed
CompletedNCT00984893
Intra-venous Zoledronic Acid Once Yearly
A Real-world Study Cohort of Postmenopausal Women With Osteoporosis Taking Zoledronic Acid or Oral Bisphosphonates
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,551 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The study will assess the real life effectiveness of zoledronic acid in the management of patients with osteoporosis over 4 years of treatment. Zoledronic acid will be compared to oral bisphosphonates (OBP) with respect to the change in Bone Mineral Density (BMD) and incidence of fractures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | zoledronic acid | |
| DRUG | Any oral bisphosphonates marketed in Canada |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2009-09-25
- Last updated
- 2016-03-04
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00984893. Inclusion in this directory is not an endorsement.